Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Analysts
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three ratings firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation, fifteen have given a buy recommendation and one has issued […]
24 Dec 08:58 · The Markets Daily